EU Approves P&G Takeover of Teva Drugs Division

Oct. 2, 2011
In March the companies announced the acquisition covering pain-relief and other products with sales of around a billion dollars.

The European Commission gave its green light on Sept. 30 to the takeover by Procter & Gamble of the 'over-the-counter' division of Israeli drugmaker Teva.

Anti-trust inspectors "concluded that the proposed transaction would not raise competition concerns, because the merged entity would continue to face sufficient competition in the markets concerned," Brussels said.

The companies announced in March the tie-up covering pain-relief and other products with sales of around a billion dollars.

Copyright Agence France-Presse, 2011

Popular Sponsored Recommendations

Empowering the Modern Workforce: The Power of Connected Worker Technologies

March 1, 2024
Explore real-world strategies to boost worker safety, collaboration, training, and productivity in manufacturing. Emphasizing Industry 4.0, we'll discuss digitalization and automation...

3 Best Practices to Create a Product-Centric Competitive Advantage with PRO.FILE PLM

Jan. 25, 2024
Gain insight on best practices and strategies you need to accelerate engineering change management and reduce time to market. Register now for your opportunity to accelerate your...

Transformative Capabilities for XaaS Models in Manufacturing

Feb. 14, 2024
The manufacturing sector is undergoing a pivotal shift toward "servitization," or enhancing product offerings with services and embracing a subscription model. This transition...

Shifting Your Business from Products to Service-Based Business Models: Generating Predictable Revenues

Oct. 27, 2023
Executive summary on a recent IndustryWeek-hosted webinar sponsored by SAP

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!